ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 191 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,097,724 | -48.7% | 977,200 | -19.6% | 0.01% | -46.7% |
| Q2 2023 | $6,037,059 | -5.6% | 1,214,700 | -6.2% | 0.02% | -6.2% |
| Q1 2023 | $6,396,312 | +5.9% | 1,294,800 | +34.8% | 0.02% | -5.9% |
| Q4 2022 | $6,040,916 | +151.4% | 960,400 | +331.6% | 0.02% | +142.9% |
| Q3 2022 | $2,403,000 | +59.0% | 222,500 | +67.9% | 0.01% | +75.0% |
| Q2 2022 | $1,511,000 | -28.7% | 132,500 | -43.0% | 0.00% | -33.3% |
| Q1 2022 | $2,118,000 | +19.8% | 232,500 | +242.9% | 0.01% | +20.0% |
| Q2 2021 | $1,768,000 | -87.9% | 67,800 | -83.6% | 0.01% | -87.5% |
| Q1 2021 | $14,618,000 | +64.6% | 414,100 | +17.7% | 0.04% | +66.7% |
| Q4 2020 | $8,879,000 | -30.2% | 351,800 | +4.2% | 0.02% | -33.3% |
| Q3 2020 | $12,727,000 | +822.9% | 337,500 | +948.1% | 0.04% | +800.0% |
| Q2 2020 | $1,379,000 | – | 32,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $5,700,177 | 8.82% |
| Wildcat Capital Management, LLC | 1,920,787 | $6,088,895 | 2.44% |
| TPG GP A, LLC | 18,716,306 | $59,330,690 | 1.02% |
| EcoR1 Capital, LLC | 4,488,200 | $14,227,594 | 0.48% |
| CROSSPOINT FINANCIAL, LLC | 12,000 | $38,040 | 0.40% |
| Coastal Bridge Advisors, LLC | 406,847 | $1,289,705 | 0.35% |
| CAXTON ASSOCIATES LP | 480,104 | $1,521,930 | 0.21% |
| Woodline Partners LP | 5,313,915 | $16,845,111 | 0.20% |
| Rhenman & Partners Asset Management AB | 300,000 | $951,000 | 0.10% |
| Navalign, LLC | 75,365 | $238,907 | 0.09% |